Hims & Hers Health, Inc.
NYSE:HIMS
51.96 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 586.01 | 481.139 | 401.556 | 315.648 | 278.171 | 246.619 | 226.699 | 207.912 | 190.77 | 167.203 | 144.836 | 113.563 | 101.314 | 84.699 | 74.173 | 60.692 | 52.314 | 41.466 | 41.324 | 35.904 | 30.063 | 24.769 | 21.684 | 18.053 | 18.053 |
| Cost of Revenue
| 155.321 | 111.598 | 83.67 | 100.488 | 49.076 | 45.219 | 39.391 | 37.754 | 37.345 | 34.866 | 30.383 | 26.387 | 26.558 | 22.601 | 19.301 | 13.415 | 12.067 | 9.574 | 10.047 | 10.242 | 9.444 | 9.638 | 9.435 | 9.44 | 9.44 |
| Gross Profit
| 430.689 | 369.541 | 317.886 | 215.16 | 229.095 | 201.4 | 187.308 | 170.158 | 153.425 | 132.337 | 114.453 | 87.176 | 74.756 | 62.098 | 54.872 | 47.277 | 40.247 | 31.892 | 31.277 | 25.662 | 20.619 | 15.131 | 12.249 | 8.613 | 8.613 |
| Gross Profit Ratio
| 0.735 | 0.768 | 0.792 | 0.682 | 0.824 | 0.817 | 0.826 | 0.818 | 0.804 | 0.791 | 0.79 | 0.768 | 0.738 | 0.733 | 0.74 | 0.779 | 0.769 | 0.769 | 0.757 | 0.715 | 0.686 | 0.611 | 0.565 | 0.477 | 0.477 |
| Reseach & Development Expenses
| 29.914 | 23.749 | 21.092 | 18.654 | 15.324 | 13.405 | 12.27 | 11.804 | 10.748 | 8.311 | 7.977 | 6.861 | 6.088 | 5.572 | 6.242 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 48.61 | 48.028 | 44.617 | 40.554 | 34.568 | 32.319 | 35.907 | 31.144 | 30.513 | 27.568 | 47.997 | 46.876 | 43.582 | 40.956 | 44.24 | 36.74 | 61.698 | 17.204 | 19.496 | 14.841 | 14.064 | 15.492 | 17.657 | 11.357 | 11.357 |
| Selling & Marketing Expenses
| 231.235 | 221.085 | 182.284 | 144.922 | 130.553 | 125.895 | 116.076 | 107.219 | 97.245 | 85.542 | 78.462 | 60.49 | 48.093 | 42.707 | 38.293 | 27.944 | 26.958 | 19.314 | 15.102 | 11.8 | 12.773 | 13.173 | 14.115 | 17.934 | 17.934 |
| SG&A
| 279.845 | 269.742 | 226.901 | 184.847 | 165.121 | 210.124 | 151.983 | 138.363 | 127.758 | 113.11 | 126.459 | 107.366 | 91.675 | 83.663 | 82.533 | 64.684 | 88.656 | 36.518 | 34.598 | 26.641 | 26.837 | 28.665 | 31.772 | 29.291 | 29.291 |
| Other Expenses
| 0 | 57.454 | 0 | 2.394 | 2.5 | 2.596 | 1.638 | 2.066 | 26.182 | 22.521 | 0.677 | 0.402 | 0.32 | 0.125 | 0.219 | 0.325 | -2.905 | -0.579 | 0.008 | 0.056 | 0.23 | 0.283 | 0 | 0 | 0 |
| Operating Expenses
| 309.759 | 350.945 | 295.512 | 203.501 | 219.192 | 210.124 | 195.862 | 179.394 | 164.688 | 143.942 | 134.436 | 107.366 | 91.675 | 83.663 | 82.533 | 64.684 | 88.656 | 36.518 | 34.598 | 26.641 | 26.837 | 28.665 | 31.488 | 29.407 | 29.407 |
| Operating Income
| 57.897 | 18.596 | 22.374 | 11.659 | 9.903 | -8.724 | -8.554 | -9.236 | -11.263 | -11.605 | -19.983 | -20.19 | -16.919 | -21.565 | -27.661 | -17.407 | -48.409 | -4.626 | -3.321 | -0.979 | -6.218 | -13.534 | -19.523 | -20.679 | -20.679 |
| Operating Income Ratio
| 0.099 | 0.039 | 0.056 | 0.037 | 0.036 | -0.035 | -0.038 | -0.044 | -0.059 | -0.069 | -0.138 | -0.178 | -0.167 | -0.255 | -0.373 | -0.287 | -0.925 | -0.112 | -0.08 | -0.027 | -0.207 | -0.546 | -0.9 | -1.145 | -1.145 |
| Total Other Income Expenses Net
| 2.598 | 3.695 | 1.219 | 2.394 | 2.5 | 2.596 | 1.638 | 2.066 | 1.582 | 0.577 | 1.127 | 0.523 | 0.761 | -9.683 | 8.547 | 8.288 | -2.905 | -0.579 | -2.519 | 0.035 | 0.22 | 1.201 | 0.88 | 0.18 | 0.18 |
| Income Before Tax
| 60.495 | 22.291 | 23.593 | 13.424 | 12.403 | 2.196 | -6.916 | -7.17 | -9.681 | -11.028 | -18.856 | -19.667 | -16.158 | -31.248 | -19.114 | -9.119 | -51.314 | -5.205 | -5.84 | -0.944 | -5.998 | -12.333 | -18.643 | -20.499 | -20.499 |
| Income Before Tax Ratio
| 0.103 | 0.046 | 0.059 | 0.043 | 0.045 | 0.009 | -0.031 | -0.034 | -0.051 | -0.066 | -0.13 | -0.173 | -0.159 | -0.369 | -0.258 | -0.15 | -0.981 | -0.126 | -0.141 | -0.026 | -0.2 | -0.498 | -0.86 | -1.136 | -1.136 |
| Income Tax Expense
| -11.01 | -3.734 | -51.995 | 0.127 | 1.275 | 0.951 | 0.651 | -0.013 | 0.386 | -0.121 | -0.016 | 0.012 | 0.094 | -0.087 | -3.173 | 0.034 | 0.09 | 0.024 | 0.031 | 0.037 | 0.035 | 0.023 | 0.022 | 0.023 | 0.023 |
| Net Income
| 49.485 | 26.025 | 75.588 | 13.297 | 11.128 | 1.245 | -7.567 | -7.157 | -10.067 | -10.907 | -18.84 | -19.679 | -16.252 | -31.161 | -15.941 | -9.153 | -51.404 | -5.229 | -5.871 | -0.981 | -6.033 | -12.356 | -18.665 | -20.522 | -20.522 |
| Net Income Ratio
| 0.084 | 0.054 | 0.188 | 0.042 | 0.04 | 0.005 | -0.033 | -0.034 | -0.053 | -0.065 | -0.13 | -0.173 | -0.16 | -0.368 | -0.215 | -0.151 | -0.983 | -0.126 | -0.142 | -0.027 | -0.201 | -0.499 | -0.861 | -1.137 | -1.137 |
| EPS
| 0.22 | 0.12 | 0.35 | 0.062 | 0.05 | 0.006 | -0.036 | -0.034 | -0.049 | -0.053 | -0.092 | -0.097 | -0.08 | -0.15 | -0.08 | -0.048 | -0.34 | -0.066 | -0.16 | -0.028 | -0.17 | -0.36 | -0.24 | -0.27 | -0.27 |
| EPS Diluted
| 0.2 | 0.11 | 0.32 | 0.057 | 0.05 | 0.006 | -0.036 | -0.034 | -0.049 | -0.053 | -0.092 | -0.097 | -0.08 | -0.15 | -0.08 | -0.048 | -0.34 | -0.066 | -0.16 | -0.028 | -0.17 | -0.36 | -0.24 | -0.27 | -0.27 |
| EBITDA
| 57.897 | 24.657 | 26.757 | 14.673 | 12.904 | 2.258 | -6.191 | -6.859 | -8.717 | -11.605 | -16.954 | -18.369 | -15.178 | -29.618 | -26.115 | -17.407 | -48.015 | -4.261 | -3.013 | -0.767 | -6.038 | -13.519 | -19.428 | -20.671 | -20.671 |
| EBITDA Ratio
| 0.099 | 0.051 | 0.067 | 0.046 | 0.046 | 0.009 | -0.027 | -0.033 | -0.046 | -0.069 | -0.117 | -0.162 | -0.15 | -0.35 | -0.352 | -0.287 | -0.918 | -0.103 | -0.073 | -0.021 | -0.201 | -0.546 | -0.896 | -1.145 | -1.145 |